Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.HU |
First Approval Date01 Jan 2007 |
100 Clinical Results associated with Omninvest LLC
0 Patents (Medical) associated with Omninvest LLC
100 Deals associated with Omninvest LLC
100 Translational Medicine associated with Omninvest LLC